Professional Documents
Culture Documents
The Relationship Between Rate of Algometer Application and Pain Pressure Threshold in the
Assessment of Myofascial Trigger Point Sensitivity
Maneil Joshi
Research Assistant
School of Human Kinetics
University of Ottawa
Ottawa, Ontario
This article has been accepted for publication and undergone full peer review but has not
been through the copyediting, typesetting, pagination and proofreading process, which may
lead to differences between this version and the Version of Record. Please cite this article as
doi: 10.1111/papr.12597
both regional and widespread musculoskeletal pain. Despite its acceptance amongst
clinicians and scientists, the relationship between rate of pressure application (RoA) and pain
pressure threshold (PPT) remains poorly understood. We set out to test the hypothesis that a
strong, positive, linear relationship exists between the RoA and the PPT within the
Methods: Thirty-three (n=33) participants were randomly recruited from the local university
community. PPT measures were recorded from a clinically identified myofascial trigger point
(MTrP) within the right infraspinatus muscle during pressure algometry. A total of two PPT
measures were recorded using each of three different RoA including low (15N/s), medium
(35N/s), and high (55N/s). Three baseline trials were also conducted at 30N/s. The Pearson’s
correlation coefficient (R) between RoA and PPT was calculated for each subject and
Results: The mean correlation between subjects was 0.77(0.19) and the average slope of the
Conclusion: Our results demonstrate that there is a strong, linear relationship between the
RoA and PPT when using the pressure algometry technique. The low slope between RoA and
PPT suggests clinicians can rely on PPT assessments despite small RoA fluctuations. Future
research should explore this relationship further in a clinical population and in other muscles
affected by chronic myofascial pain. Advancing cost effective, reliable, and clinically feasible
Trigger Point
Introduction:
regional and widespread musculoskeletal pain, including myofascial pain syndrome (MPS)
and fibromyalgia (FM)1. The prevalence of these conditions is high, with FM reported to
affect an estimated 2% of the population in the United States1,2. Limited data on the
prevalence of MPS exists, owing to the inconsistency in its diagnosis and classification1,3. One
source reports that it may account for up to 85% of visits to chronic pain centers4. The largest
diagnostic criteria1,5,6. The need to advance validated and clinically feasible assessment tools,
such as pressure algometry, is essential to the reliable diagnosis and effective management
Diagnosis of MPS and FM is often predicated on the Pain Pressure Threshold (PPT)
measured over myofascial trigger points (MTrP) or tender points respectively1. The PPT is
determined by applying an algometer, or force gauge, against a region of interest until the
potentially confounding factor, in this assessment is the rate of application (RoA) of the
studies were limited to PPT values recorded from the oral mucosa10 and the masseter and
temporalis muscle bellies9. No studies have investigated the impact of RoA on PPT in
myofascial trigger points located within muscles commonly affected by myofascial pain.
The purpose of the present study was to determine the association between RoA and
the PPT outcome during the algometric assessment of a clinically identified myofascial trigger
point locus within a muscle commonly affected by MPS. We set out to test the hypothesis
that a strong positive, linear relationship exists between the RoA and the PPT outcome during
algometry of a MTrP locus within the infraspinatus in young healthy subjects. The findings of
this study provide important foundational data needed to advance the technique of
algometry for the reliable evaluation of musculoskeletal pain in both clinical and research
settings.
2.1 Participants:
A total of thirty-three (n=33) young healthy adults were randomly recruited from the
local university community (Table 1). All study protocols were approved by the university
research ethics board and were conducted according to the Code of Ethics of the World
Medical Association (Declaration of Helsinki, 2000) for experiments involving humans. All
neck/shoulder injuries, facet irritation or neurological disorders. Subject inclusion was based
on the identification of a MTrP locus within in the right infraspinatus muscle using the
accepted diagnostic criteria of a taut, palpable and tender nodule during manual palpation1.
The location of the trigger point was marked with a non-toxic marker to ensure consistent
identification of the trigger point locus throughout the trial. The same experimenter, with
over 20 years of clinical experience assessing and treating MPS, identified the myofascial
2.2 Equipment:
algometer (Chatillon DFE, Ametek, Florida, USA) with a 3-cm2 hard foam tip11 to provide blunt
ended pressure in the assessment of myofascial trigger points12. Real-time PPT force data
was displayed throughout the trial using a custom-designed Labview program (National
Instruments Corporation, Texas, USA). This was to ensure that the experimenter was able to
accurately control the RoA (N/s) using real-time visual feedback. PPT Force data was sampled
at 100Hz. An electronic wired hand-held remote with a single button activation was held by
participants throughout the trial and participants were instructed to press the button at the
moment they felt the sensation over the trigger point change from pressure to pain. This
activated a sound to alert the experimenter to cease pressure application and the
Participants were asked to lay prone on a physiotherapy table for the duration of all
PPT assessments. All PPT assessments were performed over a MTrP site within the right
infraspinatus muscle while holding the wired remote in their left hand throughout the trial.
All MTrP loci were clinically identified by the same experimenter with over 20 years in the
diagnosis and management of chronic musculoskeletal pain. The pressure algometer was
aligned perpendicularly on the skin over the clinically identified MTrP site while pressure was
consistently applied downward onto the MTrP site. Participants were instructed to press the
Three baseline trials were completed to familiarize participants with the protocol. The
RoA for baseline trials was maintained at 30 N/s. Following the baseline trials, an additional 6
trials were completed consisting of two trials each using a low (15 N/s), medium (35 N/s) and
high (55 N/s) RoA. A minimum 10-second rest period was given between each trial. All rates
were maintained by the experimenter using realtime visual feedback and the order of the 6
rate variable trials was randomized using a computer generated randomization. Subjects
were blinded to the RoA. The range of RoA employed in the present study was larger than
previous studies9,10 to ensure that we tested the full spectrum of RoA values on PPT
outcomes.
Mathworks, Natic, MA, USA). The PPT measurement at the moment the button was pressed
was used as the primary outcome for each trial. The RoA was calculated based on the slope
of the PPT force tracing from the moment of onset (value above 2N) until the button was
pressed. The consistency of the RoA was determined as the linear regression R2 value of the
PPT tracing from onset to button press. Values with an R2 less than 0.90 were removed to
ensure only PPT data from consistent RoA trials were used in the analysis.
The Pearson’s correlation coefficient between RoA and PPT was calculated for each
individual participant’s rate trials. A linear regression between RoA and PPT was performed
for each of the individual participant’s rate trials with the slope and Y-intercept reported. All
statistical analysis was completed in SPSS (SPSS Inc. Released 2013, IBM SPSS Statistics for
Results:
The RoA throughout the trials was very consistent both within and between
participants. A total of 198 PPT trials were performed and, of these, only 4 trials were
excluded due to an R2 value below 0.90 for the rate of application, leaving 194 trials for
analysis.
The Pearson’s correlation between RoA and PPT showed a strong positive, linear
relationship (0.78±0.19) (Figure 1, Table 2, and Table 3). The slope of the linear regressions
across all participants was low (0.13±0.09) (Figure 2, Table 2, and Table 3).
relationship exists between RoA and PPT outcome during pressure algometry of the
infraspinatus muscle. This study is the first to examine the relationship between RoA and PPT
during the algometric assessment of MTrP and our data demonstrates a significant
correlation (0.78±0.19) (Figure 1, Table 2, and Table 3) between the RoA and the PPT value in
young healthy adults. Our methodology is also the first to employ a correlation analysis of the
RoA between trials in order to ensure the consistency and reliability of RoA values
throughout our testing protocol. Our observation of a strong correlation between RoA and
PPT is in line with previous literature that has similarly reported positive linear relationships
between PPT and RoA in the orofacial tissues9,10. List et al. (1991)9 reported a correlation
0.99. The slight differences in correlation between our data and these previous studies may
be due to the location of PPT testing. Additionally, our data was sampled across a larger
range of RoA (7.6-175 N/s, or approximately 0.26-5.95 kg/cm2/s) in comparison to both List
(0.5 – 2.8 kg/cm2/s, or approximately 4.9 – 27.44 N/s.)9 and Ogimoto (50-225g/s, or
approximately 0.5 – 2.21 N/s)10. Furthermore, Ogimoto’s correlation was calculated on the
mean values of each of their five applied rates; in comparison we calculated across all
While the present data support the existence of strong, positive relationships
between RoA and PPT, the clinical relevance of this relationship is still poorly understood.
Although our data demonstrates a strong association between RoA and PPT, it also
demonstrates a weak effect of RoA on PPT (slope, 0.13±0.09) (Figure 2, Table 2, and Table 3).
significant RoA difference of 166.7 N/s (based on the mean slope of 0.13 (Figure 2)) would be
necessary to evoke a 20N difference in PPT readings. While this suggests that RoA may not
have a clinically meaningful impact on PPT, we observed significant variability in our data.
Within the large range of slopes reported, the maximum value of 0.52 still suggests relatively
large changes in RoA are required to induce clinically meaningful differences in PPT (Table 2,
Table 3). Future studies should aim to advancing our understanding of the important
Limitations
The results of this study should be interpreted in light of the following limitations. A
number of variables may contribute to the clinical manifestation of the PPT reading.
Subcutaneous tissue thickness and depth of the palpated trigger point may potentially
contribute to variability in the raw PPT measure between subjects. We aimed to mitigate this
effect by using the infraspinatus muscle, which is superficial and easily accessible via
palpation. It is also possible that differences in PPT may have been exaggerated with the
higher RoA we employed in this study. This may be due to a delayed reaction time of
participants in activating the hand-held trigger at the perceived PPT threshold during higher
RoA, potentially leading to an overshoot of the true PPT value. This phenomenon may be an
study was to investigate the relationship between PPT and RoA in a young healthy sample,
providing novel insight into our understanding of this relationship under normal healthy
association exists between RoA and PPT in chronic musculoskeletal pain populations as well
as in other muscles commonly affected by chronic musculoskeletal pain such as lumbar and
pelvis.
Conclusion:
sensitivity of MTrP. Despite its acceptance amongst both the clinical and research
community, the effect of RoA on the PPT measure is still poorly understood. Ours is the first
study to directly examine this relationship within the infraspinatus muscle, a commonly
affected muscle in the clinical manifestation of chronic myofascial pain. Our study
demonstrates that a significant, positive relationship exists between the RoA and the PPT in
the algometric assessment of myofascial trigger points in young healthy subjects. The low
slope of the strong relationship between RoA and PPT is clinically meaningful. Clinicians
should be confident in PPT outcomes despite small fluctuations in RoA during an algometry
assessment. Future research should explore this relationship further in a clinical population
and in other muscles commonly affected by chronic myofascial pain, including the spine and
pelvis. Given the prevalence of chronic myofascial pain and the need for a clinically reliable
and feasible tool to quantify pressure sensitivity in affected muscles, further research in this
Acknowledgements:
None.
References:
2. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990
3. Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal
4. Fishbain DA, Goldberg M, Robert Meagher B, Steele R, Rosomoff H. Male and female
1986;26(2):181-197.
5. Tough EA, White AR, Richards S, Campbell J. Variability of criteria used to diagnose
myofascial trigger point pain syndrome - evidence from a review of the literature. Clin
J Pain. 2007;23(3):278-286.
7. Kinser AM, Sands WA, Stone MH. Reliability and validity of a pressure algometer. J
algometry on the neck muscles for clinical use. Man Ther. 2007;12(2):192–197.
2002;29(7):620–6.
11. Srbely JZ, Dickey JP, Lowerison M, Edwards a M, Nolet PS, Wong LL. Stimulation of
12. Treede RD, Rolke R, Andrews K, Magerl W. Pain elicited by blunt pressure:
13. Fischer AA. Documentation of myofascial trigger points. Archives of Physical Medicine
N 33 (14 males)
Table 2: Overall relationships between rate of application (N/s) (RoA) and pain pressure
threshold (N) (PPT).
Mean ± SD 0.78±0.19
Mean ± SD 0.13±0.09